Eli Lilly and Company LLY | NYSE

$767.76 $10.22 | 1.35%

After Hours
$781.88 $14.12 | 1.84%

Company Overview:

Market Cap: $728.85B
PE Ratio: 83
52-Week Range: $567.42 - $972.53
Dividend Yield (FWD): 0.78% ($6.00)

10 Year Performance Metrics:

Total Return (with DRIP): 1,195.99% (29.20% / yr)
Total Return (no DRIP): 1,018.33% (27.31% / yr)
Share Price: 974.99%
Dividend Increase: 160.00%
LLY 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

LLY Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
LLY Dividend CAGR:1Y: 15.38%2Y: 15.21%5Y: 15.18%10Y: 11.61%
Share Price
LLY Price CAGR:1Y: 34.65%2Y: 46.11%5Y: 42.12%10Y: 26.63%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

LLY Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - LLY
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - LLY
14-Day FREE Trial Get Full Access Now!

LLY Earnings, Revenue, Cash & Debt, Shares Outstaning:

LLY - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
LLY - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
LLY - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
LLY - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
LLY - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
LLY - Cash & Debt
14-Day FREE Trial Get Full Access Now!
LLY - Revenue
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 20.43%2Y: 28.37%5Y: 15.87%10Y: 8.90%
LLY - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
LLY EPS CAGR:1Y: 1,777.12%2Y: -18.48%5Y: -4.82%10Y: 8.57%
LLY - Net Income
14-Day FREE Trial Get Full Access Now!
LLY Net Income CAGR:1Y: 1,790.42%2Y: -18.24%5Y: -5.00%10Y: 6.84%
LLY - EBITDA
14-Day FREE Trial Get Full Access Now!
LLY EBITDA CAGR:1Y: -64.88%2Y: -3.26%5Y: 7.22%10Y: 10.55%
LLY - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow CAGR:1Y: -74.67%2Y: N/A5Y: N/A10Y: N/A
LLY - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow / Share CAGR:1Y: -74.70%2Y: N/A5Y: N/A10Y: N/A
LLY - Gross Profit
14-Day FREE Trial Get Full Access Now!
LLY Gross Profit CAGR:1Y: 21.34%2Y: 31.47%5Y: 16.59%10Y: 9.89%
LLY - Expenses
14-Day FREE Trial Get Full Access Now!
LLY Expenses CAGR:1Y: 4.24%2Y: 159.32%5Y: 64.99%10Y: 21.83%
LLY - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
LLY Shares Outstanding CAGR:1Y: 0.58%2Y: 0.07%5Y: -0.30%10Y: -1.70%
LLY - Share Buybacks
14-Day FREE Trial Get Full Access Now!
LLY Share Buybacks CAGR:1Y: N/A2Y: N/A5Y: -5.76%10Y: 4.05%
LLY - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
LLY Stock-Based Comp CAGR:1Y: -38.22%2Y: 25.11%5Y: 12.02%10Y: 13.22%
LLY - Dividends
14-Day FREE Trial Get Full Access Now!
LLY Dividend CAGR:1Y: 15.38%2Y: 15.21%5Y: 15.18%10Y: 11.61%
LLY - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 20.43%2Y: 28.37%5Y: 15.87%10Y: 8.90%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

LLY - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual Revenue CAGR:1Y: 20.43%2Y: 28.37%5Y: 15.87%10Y: 8.90%
LLY - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual EPS CAGR:1Y: 1,777.12%2Y: -18.48%5Y: -4.82%10Y: 8.57%
LLY - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual Net Income CAGR:1Y: 1,790.42%2Y: -18.24%5Y: -5.00%10Y: 6.84%
LLY - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual EBITDA CAGR:1Y: -64.88%2Y: -3.26%5Y: 7.22%10Y: 10.55%

Ratios, Profit Margins & Return on Capital:

LLY - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
LLY Net Profit Margin CAGR:1Y: 1,513.33%2Y: -36.32%5Y: -18.02%10Y: -1.90%
LLY - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
LLY Gross Profit Margin CAGR:1Y: 0.75%2Y: 2.41%5Y: 0.62%10Y: 0.91%
LLY - Price to Earnings
14-Day FREE Trial Get Full Access Now!
LLY - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
LLY - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
LLY - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

LLY Dividends Info:

Annual Dividend: $6.00
Forward Yield: 0.78%
Ex-Dividend Date: 2025-02-14
Lifetime Dividens / Share: $66.25

LLY Dividend History: Dates, Payments & Yield list

Below is a schedule of all LLY dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
02/14/202503/10/2025$1.5000.7%0.78%$767.76
11/15/202412/10/2024$1.3000.7%0.7%$746.20
08/15/202409/10/2024$1.3000.54%0.56%$931.58
05/15/202406/10/2024$1.3000.62%0.66%$787.02
02/14/202403/08/2024$1.3000.62%0.69%$757.31
11/14/202312/08/2023$1.1300.74%0.74%$610.82
08/14/202309/08/2023$1.1300.81%0.84%$538.00
05/12/202306/09/2023$1.1300.97%1.04%$434.43
02/14/202303/10/2023$1.1301.17%1.3%$347.56
11/14/202212/09/2022$0.9801.1%1.1%$356.06
08/12/202209/09/2022$0.9801.23%1.27%$308.08
05/13/202206/10/2022$0.9801.26%1.34%$291.63
02/14/202203/10/2022$0.9801.5%1.67%$234.69
11/12/202112/10/2021$0.8501.31%1.31%$259.65
08/12/202109/10/2021$0.8501.25%1.29%$263.47
05/13/202106/10/2021$0.8501.63%1.74%$194.94
02/11/202103/10/2021$0.8501.52%1.68%$202.58
11/12/202012/10/2020$0.7402.1%2.1%$141.03
08/13/202009/10/2020$0.7401.9%1.97%$150.46
05/14/202006/10/2020$0.7401.75%1.87%$158.38
02/13/202003/10/2020$0.7401.89%2.09%$141.80
11/14/201912/10/2019$0.6452.32%2.32%$111.39
08/14/201909/10/2019$0.6452.26%2.34%$110.29
05/16/201906/10/2019$0.6452.07%2.21%$116.73
02/14/201903/08/2019$0.6451.93%2.14%$120.75
11/14/201812/10/2018$0.5632.05%2.05%$109.81
08/14/201809/10/2018$0.5632.15%2.2%$102.44
05/16/201806/08/2018$0.5632.67%2.77%$81.18
02/14/201803/09/2018$0.5632.76%2.92%$77.03
11/14/201712/08/2017$0.5202.52%2.52%$82.49
08/11/201709/08/2017$0.5202.55%2.56%$81.15
05/11/201706/09/2017$0.5202.57%2.59%$80.22
02/13/201703/10/2017$0.5202.64%2.67%$77.77
11/10/201612/09/2016$0.5102.6%2.6%$78.34
08/11/201609/09/2016$0.5102.52%2.53%$80.56
05/11/201606/10/2016$0.5102.65%2.67%$76.31
02/10/201603/10/2016$0.5102.75%2.79%$73.07
11/10/201512/10/2015$0.5002.5%2.5%$80.06
08/12/201509/10/2015$0.5002.39%2.4%$83.38
05/14/201506/10/2015$0.5002.71%2.74%$73.06
02/11/201503/10/2015$0.5002.82%2.86%$69.95
11/12/201412/10/2014$0.4902.91%2.91%$67.40
08/13/201409/10/2014$0.4903.23%3.23%$60.59
05/13/201406/10/2014$0.4903.26%3.26%$60.04
02/12/201403/10/2014$0.4903.68%3.68%$53.32
11/13/201312/10/2013$0.4903.88%3.88%$50.55
08/13/201309/10/2013$0.4903.57%3.57%$54.96
05/14/201306/10/2013$0.4903.51%3.51%$55.87
02/13/201303/08/2013$0.4903.67%3.67%$53.44
11/13/201212/10/2012$0.4904.16%4.16%$47.14
08/13/201209/10/2012$0.4904.58%4.58%$42.81
05/11/201206/08/2012$0.4904.75%4.75%$41.26
02/13/201203/09/2012$0.4905.05%5.05%$38.85
11/10/201112/09/2011$0.4905.26%5.26%$37.23
08/11/201109/09/2011$0.4905.55%5.55%$35.30
05/11/201106/10/2011$0.4905.12%5.12%$38.28
02/11/201103/10/2011$0.4905.68%5.68%$34.52
11/10/201012/10/2010$0.4905.6%5.6%$34.99
08/11/201009/10/2010$0.4905.34%5.34%$36.71
05/12/201006/10/2010$0.4905.64%5.64%$34.78
02/10/201003/10/2010$0.4905.74%5.74%$34.17
11/10/200912/10/2009$0.4905.56%5.56%$35.25
08/12/200909/10/2009$0.4905.89%5.95%$32.94
05/13/200906/10/2009$0.4905.46%5.58%$35.15
02/11/200903/10/2009$0.4905.17%5.34%$36.72
11/12/200812/10/2008$0.4705.88%5.88%$31.99
08/13/200809/10/2008$0.4703.79%3.89%$48.38
05/13/200806/10/2008$0.4703.76%3.95%$47.55
02/13/200803/10/2008$0.4703.47%3.73%$50.34
11/13/200712/10/2007$0.4253.23%3.23%$52.64
08/13/200709/10/2007$0.4252.94%2.99%$56.93
05/11/200706/08/2007$0.4252.82%2.91%$58.43
02/13/200703/09/2007$0.4252.99%3.13%$54.28
11/13/200612/08/2006$0.4002.96%2.96%$54.06
08/11/200609/08/2006$0.4002.91%2.94%$54.36
05/11/200606/09/2006$0.4003.05%3.13%$51.12
02/13/200603/10/2006$0.4002.78%2.89%$55.35
11/10/200512/09/2005$0.3802.96%2.96%$51.40
08/11/200509/09/2005$0.3802.79%2.83%$53.64
05/11/200506/10/2005$0.3802.5%2.59%$58.75
02/11/200503/10/2005$0.3802.6%2.74%$55.50
11/10/200412/10/2004$0.3552.55%2.55%$55.62
08/11/200409/10/2004$0.3552.24%2.27%$62.60
05/12/200406/10/2004$0.3551.87%1.93%$73.71
02/11/200403/10/2004$0.3551.82%1.9%$74.70
11/12/200312/10/2003$0.3352.02%2.02%$66.19
08/13/200309/10/2003$0.3352.11%2.15%$62.20
05/13/200306/10/2003$0.3352.02%2.1%$63.80
02/12/200303/10/2003$0.3352.15%2.28%$58.89
11/13/200212/10/2002$0.3102.06%2.06%$60.29
08/13/200209/10/2002$0.3102.16%2.21%$56.00
05/13/200206/10/2002$0.3101.83%1.92%$64.58
02/13/200203/08/2002$0.3101.51%1.63%$76.12
11/13/200112/10/2001$0.2801.42%1.42%$78.97
08/13/200109/10/2001$0.2801.4%1.43%$78.46
05/11/200106/11/2001$0.2801.29%1.33%$83.90
02/13/200103/09/2001$0.2801.33%1.4%$79.99
11/13/200012/11/2000$0.2601.21%1.21%$86.13
08/11/200009/11/2000$0.2601.31%1.35%$77.00
05/11/200006/09/2000$0.2601.31%1.39%$74.88
02/11/200003/10/2000$0.2601.54%1.69%$61.63
11/10/199912/10/1999$0.2301.21%1.21%$75.94
08/11/199909/10/1999$0.2301.45%1.5%$61.50
05/12/199906/10/1999$0.2301.13%1.2%$76.44
02/10/199903/10/1999$0.2300.95%1.05%$87.38
11/10/199812/10/1998$0.2000.93%0.93%$85.63
08/12/199809/10/1998$0.2001.17%1.17%$68.63
05/13/199806/10/1998$0.2001.14%1.17%$68.63
02/11/199803/10/1998$0.2001.15%1.21%$66.13
11/12/199712/10/1997$0.2001.17%1.27%$63.13
08/13/199709/10/1997$0.1801.36%1.38%$52.25
05/13/199706/10/1997$0.1801.51%1.55%$46.44
02/12/199703/10/1997$0.1801.53%1.59%$45.25
11/13/199612/10/1996$0.1711.81%1.81%$37.81
08/13/199609/10/1996$0.1712.32%2.32%$29.50
05/13/199606/10/1996$0.1712.42%2.45%$27.94
02/13/199603/11/1996$0.1712.07%2.14%$32.06
11/13/199512/11/1995$0.1712.72%2.84%$24.09
08/11/199509/11/1995$0.1613.37%3.4%$18.97
05/09/199506/12/1995$0.1613.47%3.52%$18.31
02/09/199503/10/1995$0.1613.84%3.93%$16.41
11/08/199412/12/1994$0.1563.96%3.96%$15.78
08/09/199409/12/1994$0.1565.09%5.13%$12.19
05/09/199406/10/1994$0.1564.63%4.71%$13.28
02/09/199403/10/1994$0.1564.22%4.33%$14.44
11/08/199312/10/1993$0.1514.34%4.34%$13.94
08/09/199309/10/1993$0.1515.33%5.46%$11.09
05/10/199306/10/1993$0.1514.55%4.77%$12.69
02/09/199303/10/1993$0.1514.15%4.45%$13.59
11/06/199212/10/1992$0.1383.59%3.59%$15.34
08/10/199209/10/1992$0.1383.08%3.15%$17.44
05/11/199206/10/1992$0.1383.12%3.27%$16.84
02/10/199203/10/1992$0.1382.59%2.78%$19.81
11/08/199112/10/1991$0.1252.63%2.63%$19.03
08/09/199109/10/1991$0.1252.41%2.52%$19.84
05/09/199106/10/1991$0.1252.36%2.6%$19.25
02/07/199103/11/1991$0.1252.34%2.71%$18.47
11/08/199012/10/1990$0.1032.39%2.39%$17.13
08/09/199009/10/1990$0.1032.01%2.1%$19.50
05/09/199006/11/1990$0.1032.17%2.38%$17.25
02/09/199003/12/1990$0.1032.26%2.61%$15.69
11/09/198912/11/1989$0.0842.11%2.11%$16.00
08/09/198909/11/1989$0.0842.12%2.2%$15.34
05/09/198906/12/1989$0.0842.37%2.56%$13.16
02/09/198903/10/1989$0.0842.53%2.85%$11.86
11/08/198812/12/1988$0.0722.64%2.64%$10.89
08/09/198809/12/1988$0.0722.67%2.76%$10.42
05/09/198806/10/1988$0.0722.78%2.98%$9.66
02/09/198803/10/1988$0.0722.84%3.15%$9.13
11/06/198712/10/1987$0.0632.65%2.65%$9.42
08/10/198709/10/1987$0.0631.97%2.02%$12.38
05/11/198706/10/1987$0.0632.19%2.31%$10.83
02/09/198703/10/1987$0.0632.18%2.35%$10.63
11/07/198611/12/1986$0.0562.41%2.41%$9.33
08/11/198608/13/1986$0.0562.3%2.37%$9.50
05/09/198605/14/1986$0.0562.41%2.55%$8.83
02/10/198602/12/1986$0.0562.95%3.22%$6.98
11/08/198511/13/1985$0.0503.36%3.36%$5.95
08/09/198508/14/1985$0.0503.85%3.85%$5.19
05/09/198505/13/1985$0.0503.97%4.07%$4.92
02/08/198502/13/1985$0.0504.19%4.4%$4.55
11/08/198411/12/1984$0.0504.73%5.09%$3.93
08/09/198408/13/1984$0.0454.97%4.97%$3.65
05/09/198405/11/1984$0.0454.66%4.66%$3.89
02/08/198402/10/1984$0.0454.6%4.72%$3.84
11/07/198311/09/1983$0.0450%0%$0.00
08/09/198308/11/1983$0.0450%0%$0.00
05/09/198305/11/1983$0.0410%0%$0.00
02/09/198302/11/1983$0.0410%0%$0.00
11/05/198211/10/1982$0.0410%0%$0.00
08/09/198208/11/1982$0.0410%0%$0.00
05/10/198205/12/1982$0.0410%0%$0.00
02/08/198202/10/1982$0.0410%0%$0.00
11/06/198111/11/1981$0.0360%0%$0.00
08/10/198108/12/1981$0.0360%0%$0.00
05/11/198105/13/1981$0.0360%0%$0.00
02/05/198102/09/1981$0.0360%0%$0.00
11/07/198011/12/1980$0.0360%0%$0.00
08/11/198008/13/1980$0.0360%0%$0.00
05/12/198005/14/1980$0.0330%0%$0.00
02/08/198002/13/1980$0.0330%0%$0.00
11/02/197911/07/1979$0.0330%0%$0.00
08/06/197908/08/1979$0.0330%0%$0.00
05/07/197905/09/1979$0.0280%0%$0.00
02/05/197902/07/1979$0.0280%0%$0.00
11/03/197811/08/1978$0.0280%0%$0.00
08/07/197808/09/1978$0.0250%0%$0.00
05/08/197805/10/1978$0.0250%0%$0.00
02/06/197802/08/1978$0.0250%0%$0.00
11/03/197711/07/1977$0.0220%0%$0.00
08/08/197708/10/1977$0.0220%0%$0.00
05/09/197705/11/1977$0.0220%0%$0.00
02/04/197702/09/1977$0.0220%0%$0.00
11/05/197611/10/1976$0.0200%0%$0.00
08/09/197608/11/1976$0.0200%0%$0.00
05/10/197605/12/1976$0.0190%0%$0.00
02/06/197602/11/1976$0.0190%0%$0.00
11/07/197511/12/1975$0.0170%0%$0.00
08/11/197508/13/1975$0.0170%0%$0.00
05/12/197505/14/1975$0.0170%0%$0.00
02/07/197502/12/1975$0.0170%0%$0.00
11/08/197411/13/1974$0.0160%0%$0.00
08/12/197408/14/1974$0.0160%0%$0.00
05/13/197405/15/1974$0.0150%0%$0.00
02/08/197402/13/1974$0.0150%0%$0.00
11/12/197311/14/1973$0.0130%0%$0.00
08/13/197308/15/1973$0.0130%0%$0.00
05/14/197305/16/1973$0.0120%0%$0.00
02/09/197302/14/1973$0.0120%0%$0.00
11/13/197211/15/1972$0.0110%0%$0.00
08/07/197208/09/1972$0.0110%0%$0.00

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for LLY

Based on past 10-year performance, here are LLY growth metrics:

Share price CAGR of +26.81%
Dividend CAGR of +11.61%
Using LLY CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

LLY
Current Price$767.76
Start Shares13.02
Start Value$10,000
 
After 10 years:
Final Share Count13.57
Dividends Payment$3.90
Annual Dividends$212
Yield on cost2.12%
Share Price$6,508.64
Total Dividends$1,199
Final Value$88,298

Estimated Future Value + Dividends - LLY

NOTE: Above numbers are our estimate based on LLY's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Eli Lilly and Company (LLY) had its IPO on 1972-06-01, and is trader on NYSE stock exchange.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

LLY website: https://www.lilly.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial